Filing Details

Accession Number:
0001179110-13-014199
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-13 19:02:46
Reporting Period:
2013-09-12
Filing Date:
2013-09-13
Accepted Time:
2013-09-13 19:02:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302443 E Rick Winningham Theravance, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-09-12 22,353 $40.03 690,106 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
  2. This transaction was executed in multiple trades at prices ranging from $40.00 to $40.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.